Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Bronchiectasis in India: results from the European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) and Respiratory Research Network of India Registry.

Dhar R, Singh S, Talwar D, Mohan M, Tripathi SK, Swarnakar R, Trivedi S, Rajagopala S, D'Souza G, Padmanabhan A, Baburao A, Mahesh PA, Ghewade B, Nair G, Jindal A, Jayadevappa GDH, Sawhney H, Sarmah KR, Saha K, Anantharaj S, Khanna A, Gami S, Shah A, Shah A, Dutt N, Garg H, Vyas S, Venugopal K, Prasad R, Aleemuddin NM, Karmakar S, Singh V, Jindal SK, Sharma S, Prajapat D, Chandrashekaria S, McDonnell MJ, Mishra A, Rutherford R, Ramanathan RP, Goeminne PC, Vasudev P, Dimakou K, Crichton ML, Jayaraj BS, Kungwani R, Das A, Sawhney M, Polverino E, Torres A, Gulecha NS, Shteinberg M, De Soyza A, Mangala A, Shah P, Chauhan NK, Jajodia N, Singhal A, Batra S, Hasan A, Limaye S, Salvi S, Aliberti S, Chalmers JD.

Lancet Glob Health. 2019 Sep;7(9):e1269-e1279. doi: 10.1016/S2214-109X(19)30327-4. Erratum in: Lancet Glob Health. 2019 Oct 9;:.

2.

New insights into immunological responses to infection in bronchiectasis.

Shteinberg M, Shah A, Elborn JS.

Eur Respir J. 2019 Feb 7;53(2). pii: 1802395. doi: 10.1183/13993003.02395-2018. Print 2019 Feb. No abstract available.

PMID:
30759421
3.

COPD Exacerbator Phenotype is Inversely Associated with Current Smoking But Not with Haptoglobin Phenotype.

Tal S, Adir Y, Stein N, Shalom H, Lache O, Levy A, Shteinberg M.

Isr Med Assoc J. 2019 Jan;21(1):19-23.

4.

Decreased Fecal Calprotectin Levels in Cystic Fibrosis Patients After Antibiotic Treatment for Respiratory Exacerbation.

Schnapp Z, Hartman C, Livnat G, Shteinberg M, Elenberg Y.

J Pediatr Gastroenterol Nutr. 2019 Feb;68(2):282-284. doi: 10.1097/MPG.0000000000002197.

PMID:
30640865
5.

The European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) ERS Clinical Research Collaboration.

Aliberti S, Polverino E, Chalmers JD, Altenburg J, Shteinberg M, Goeminne PC, Welte T, Shoemark A, Almagro M, Blasi F; EMBARC Clinical Research Collaboration.

Eur Respir J. 2018 Nov 29;52(5). pii: 1802074. doi: 10.1183/13993003.02074-2018. Print 2018 Nov. No abstract available.

PMID:
30498055
6.

Failure to conceive in women with CF is associated with pancreatic insufficiency and advancing age.

Shteinberg M, Lulu AB, Downey DG, Blumenfeld Z, Rousset-Jablonski C, Perceval M, Colombo A, Stein N, Livnat G, Gur M, Bentur L, Mussaffi H, Blau H, Sarouk I, Dagan A, Kerem E, Aviram M, Picard E, Aliberti S, Álvarez A, Miranda JP, Polverino E, Durieu I, Stuart Elborn J, Cohen-Cymberknoh M.

J Cyst Fibros. 2019 Jul;18(4):525-529. doi: 10.1016/j.jcf.2018.10.009. Epub 2018 Oct 23.

PMID:
30366850
7.

Circulating eosinophil levels do not predict severe exacerbations in COPD: a retrospective study.

Adir Y, Hakrush O, Shteinberg M, Schneer S, Agusti A.

ERJ Open Res. 2018 Aug 3;4(3). pii: 00022-2018. doi: 10.1183/23120541.00022-2018. eCollection 2018 Jul.

8.

The overlap between bronchiectasis and chronic airway diseases: state of the art and future directions.

Polverino E, Dimakou K, Hurst J, Martinez-Garcia MA, Miravitlles M, Paggiaro P, Shteinberg M, Aliberti S, Chalmers JD.

Eur Respir J. 2018 Sep 15;52(3). pii: 1800328. doi: 10.1183/13993003.00328-2018. Print 2018 Sep. Review.

PMID:
30049739
9.

The Q359K/T360K mutation causes cystic fibrosis in Georgian Jews.

Mei-Zahav M, Stafler P, Senderowitz H, Bentur L, Livnat G, Shteinberg M, Orenstein N, Bazak L, Prais D, Levine H, Gur M, Khazanov N, Simhaev L, Eliyahu H, Cohen M, Wilschanski M, Blau H, Mussaffi H.

J Cyst Fibros. 2018 Sep;17(5):e41-e45. doi: 10.1016/j.jcf.2018.06.008. Epub 2018 Jul 20.

PMID:
30033373
10.

Novel non-invasive early detection of lung cancer using liquid immunobiopsy metabolic activity profiles.

Adir Y, Tirman S, Abramovitch S, Botbol C, Lutaty A, Scheinmann T, Davidovits E, Arbel I, Davidovits G, Schneer S, Shteinberg M, Peretz Soroka H, Tirosh R, Patolsky F.

Cancer Immunol Immunother. 2018 Jul;67(7):1135-1146. doi: 10.1007/s00262-018-2173-5. Epub 2018 May 21.

PMID:
29785657
11.

Prevalence, risk factors and prognosis of nontuberculous mycobacterial infection among people with bronchiectasis: a population survey.

Shteinberg M, Stein N, Adir Y, Ken-Dror S, Shitrit D, Bendayan D, Fuks L, Saliba W.

Eur Respir J. 2018 May 10;51(5). pii: 1702469. doi: 10.1183/13993003.02469-2017. Print 2018 May. No abstract available.

PMID:
29545278
12.

[DIAGNOSIS AND TREATMENT OF BRONCHIECTASIS: POSITION PAPER OF THE ISRAELI PULMONOLOGY SOCIETY AND THE ISRAELI PEDIATRIC PULMONOLOGY SOCIETY].

Shteinberg M, Hardak E, Koslow M, Prais D, Cohen-Cymberkno M, Shoseyov D, Dagan A, Adir Y, Shitrit D.

Harefuah. 2018 Feb;157(2):117-121. Hebrew.

PMID:
29484869
13.

The independent contribution of Pseudomonas aeruginosa infection to long-term clinical outcomes in bronchiectasis.

Araújo D, Shteinberg M, Aliberti S, Goeminne PC, Hill AT, Fardon TC, Obradovic D, Stone G, Trautmann M, Davis A, Dimakou K, Polverino E, De Soyza A, McDonnell MJ, Chalmers JD.

Eur Respir J. 2018 Jan 31;51(2). pii: 1701953. doi: 10.1183/13993003.01953-2017. Print 2018 Feb.

14.

Upper airway involvement in bronchiectasis is marked by early onset and allergic features.

Shteinberg M, Nassrallah N, Jrbashyan J, Uri N, Stein N, Adir Y.

ERJ Open Res. 2018 Jan 19;4(1). pii: 00115-2017. doi: 10.1183/23120541.00115-2017. eCollection 2018 Jan.

15.

Characterization of the "Frequent Exacerbator Phenotype" in Bronchiectasis.

Chalmers JD, Aliberti S, Filonenko A, Shteinberg M, Goeminne PC, Hill AT, Fardon TC, Obradovic D, Gerlinger C, Sotgiu G, Operschall E, Rutherford RM, Dimakou K, Polverino E, De Soyza A, McDonnell MJ.

Am J Respir Crit Care Med. 2018 Jun 1;197(11):1410-1420. doi: 10.1164/rccm.201711-2202OC.

PMID:
29357265
16.

Standardised classification of the aetiology of bronchiectasis using an objective algorithm.

Araújo D, Shteinberg M, Aliberti S, Goeminne PC, Hill AT, Fardon T, Obradovic D, Dimakou K, Polverino E, De Soyza A, McDonnell MJ, Chalmers JD.

Eur Respir J. 2017 Dec 14;50(6). pii: 1701289. doi: 10.1183/13993003.01289-2017. Print 2017 Dec. No abstract available.

17.

Clinical impact of Pseudomonas aeruginosa colonization in patients with Primary Ciliary Dyskinesia.

Cohen-Cymberknoh M, Weigert N, Gileles-Hillel A, Breuer O, Simanovsky N, Boon M, De Boeck K, Barbato A, Snijders D, Collura M, Pradal U, Blau H, Mussaffi H, Price M, Bentur L, Gur M, Aviram M, Picard E, Shteinberg M, Livnat G, Rivlin J, Hiller N, Shoseyov D, Amirav I, Kerem E.

Respir Med. 2017 Oct;131:241-246. doi: 10.1016/j.rmed.2017.08.028. Epub 2017 Sep 1.

PMID:
28947038
18.

Ivacaftor for the p.Ser549Arg (S549R) gating mutation - The Israeli experience.

Dagan A, Cohen-Cymberknoh M, Shteinberg M, Levine H, Vilozni D, Bezalel Y, Bar Aluma BE, Sarouk I, Ashkenazi M, Lavie M, Tsabari R, Blau H, Kerem E, Bentur L, Efrati O, Livnat G.

Respir Med. 2017 Oct;131:225-228. doi: 10.1016/j.rmed.2017.08.026. Epub 2017 Sep 1.

PMID:
28947035
19.

Lung function and disease severity in cystic fibrosis patients heterozygous for p.Arg117His.

Shteinberg M, Downey DG, Beattie D, McCaughan J, Reid A, Stein N, Elborn JS.

ERJ Open Res. 2017 Mar 31;3(1). pii: 00056-2016. doi: 10.1183/23120541.00056-2016. eCollection 2017 Jan.

20.

Nationwide genetic analysis for molecularly unresolved cystic fibrosis patients in a multiethnic society: implications for preconception carrier screening.

Behar DM, Inbar O, Shteinberg M, Gur M, Mussaffi H, Shoseyov D, Ashkenazi M, Alkrinawi S, Bormans C, Hakim F, Mei-Zahav M, Cohen-Cymberknoh M, Dagan A, Prais D, Sarouk I, Stafler P, Bar Aluma BE, Akler G, Picard E, Aviram M, Efrati O, Livnat G, Rivlin J, Bentur L, Blau H, Kerem E, Singer A.

Mol Genet Genomic Med. 2017 Feb 19;5(3):223-236. doi: 10.1002/mgg3.278. eCollection 2017 May.

21.

[LONG TERM TREATMENT WITH MACROLIDES IN CHRONIC LUNG DISEASES].

Shteinberg M, Schneer S, Lavon O, Adir Y.

Harefuah. 2016 Sep;155(9):567-571. Review. Hebrew.

PMID:
28530085
22.

Digital Recording and Documentation of Endoscopic Procedures: Do Patients and Doctors Think Alike?

Willner N, Peled-Raz M, Shteinberg D, Shteinberg M, Keren D, Rainis T.

Can J Gastroenterol Hepatol. 2016;2016:2493470. doi: 10.1155/2016/2493470. Epub 2016 Nov 23.

23.

Changes of CFTR functional measurements and clinical improvements in cystic fibrosis patients with non p.Gly551Asp gating mutations treated with ivacaftor.

Mesbahi M, Shteinberg M, Wilschanski M, Hatton A, Nguyen-Khoa T, Friedman H, Cohen M, Escabasse V, Le Bourgeois M, Lucidi V, Sermet-Gaudelus I, Bassinet L, Livnat G.

J Cyst Fibros. 2017 Jan;16(1):45-48. doi: 10.1016/j.jcf.2016.08.006. Epub 2016 Sep 20.

24.

The EMBARC European Bronchiectasis Registry: protocol for an international observational study.

Chalmers JD, Aliberti S, Polverino E, Vendrell M, Crichton M, Loebinger M, Dimakou K, Clifton I, van der Eerden M, Rohde G, Murris-Espin M, Masefield S, Gerada E, Shteinberg M, Ringshausen F, Haworth C, Boersma W, Rademacher J, Hill AT, Aksamit T, O'Donnell A, Morgan L, Milenkovic B, Tramma L, Neves J, Menendez R, Paggiaro P, Botnaru V, Skrgat S, Wilson R, Goeminne P, De Soyza A, Welte T, Torres A, Elborn JS, Blasi F.

ERJ Open Res. 2016 Jan 20;2(1). pii: 00081-2015. eCollection 2016 Jan.

25.

Eradication failure of newly acquired Pseudomonas aeruginosa isolates in cystic fibrosis.

Cohen-Cymberknoh M, Gilead N, Gartner S, Rovira S, Blau H, Mussaffi H, Rivlin J, Gur M, Shteinberg M, Bentur L, Livnat G, Aviram M, Picard E, Tenenbaum A, Armoni S, Breuer O, Shoseyov D, Kerem E.

J Cyst Fibros. 2016 Nov;15(6):776-782. doi: 10.1016/j.jcf.2016.04.006. Epub 2016 May 1.

26.

Spontaneous Resolution of Pulmonary Langerhans Cell Histiocytosis Despite Smoking.

Shteinberg M, Yeremekno D, Adir Y.

Lung. 2016 Apr;194(2):331-2. doi: 10.1007/s00408-016-9845-8. Epub 2016 Jan 21. No abstract available.

PMID:
26791193
27.

Risk of recurrent venous thromboembolism and major hemorrhage in cancer-associated incidental pulmonary embolism among treated and untreated patients: a pooled analysis of 926 patients.

van der Hulle T, den Exter PL, Planquette B, Meyer G, Soler S, Monreal M, Jiménez D, Portillo AK, O'Connell C, Liebman HA, Shteinberg M, Adir Y, Tiseo M, Bersanelli M, Abdel-Razeq HN, Mansour AH, Donnelly OG, Radhakrishna G, Ramasamy S, Bozas G, Maraveyas A, Shinagare AB, Hatabu H, Nishino M, Huisman MV, Klok FA.

J Thromb Haemost. 2016 Jan;14(1):105-13. doi: 10.1111/jth.13172. Epub 2016 Jan 11.

28.

Lack of Association Between Haptoglobin Phenotype and Cystic Fibrosis Outcomes.

Shteinberg M, Rivlin J, Gur M, Konopnicki M, Stein N, Tunney MM, Elborn JS, Downey DG, Johnston E, Shalom H, Levy A.

Lung. 2015 Dec;193(6):1017-21. doi: 10.1007/s00408-015-9801-z. Epub 2015 Sep 14.

PMID:
26370551
29.

Survival dynamics of cystic fibrosis-related Gram-negative bacterial pathogens (Pseudomonas aeruginosa and Burkholderia cenocepacia) in Dead Sea and Atlantic Ocean waters.

Shteinberg M, Kis-Papo T, Millar BC, Rendall JC, Downey DG, Elborn JS, Moore JE.

J Water Health. 2015 Sep;13(3):773-6. doi: 10.2166/wh.2015.157.

PMID:
26322762
30.

[CYSTIC FIBROSIS SURVIVAL TRENDS IN CARMEL MEDICAL CENTER].

Nathan K, Shteinberg M, Rivlin J.

Harefuah. 2015 Jun;154(6):373-6, 404. Hebrew.

PMID:
26281081
31.

[BRONCHIECTASIS--REVIEW OF LITERATURE AND CLINICAL CHARACTERISTICS OF BRONCHIECTASIS PATIENTS TREATED IN THE BRONCHIECTASIS CLINIC AT THE CARMEL MEDICAL CENTER].

Shteinberg M, Yaari N, Stein N, Amital A, Israeli D, Adir Y.

Harefuah. 2015 Jun;154(6):356-61, 406, 405. Review. Hebrew.

PMID:
26281077
32.

Use of inhaled tobramycin in cystic fibrosis.

Shteinberg M, Elborn JS.

Adv Ther. 2015 Jan;32(1):1-9. doi: 10.1007/s12325-015-0179-3. Epub 2015 Jan 27. Review.

PMID:
25620537
33.

Asymptomatic carriage of Pneumocystis jirovecii and cytomegalovirus in lungs of immunocompetent patients.

Shteinberg M, Shaked-Mishan P, Kinarti A, Abramovitch A, Amital A, Jacobi A, Kolup Feldmann AE, Shiner M, Gershtein V, Weber G, Adir Y.

Lung. 2014 Dec;192(6):875-9. doi: 10.1007/s00408-014-9644-z. Epub 2014 Sep 9.

PMID:
25201088
34.

The association between obesity, mortality and filling pressures in pulmonary hypertension patients; the "obesity paradox".

Zafrir B, Adir Y, Shehadeh W, Shteinberg M, Salman N, Amir O.

Respir Med. 2013 Jan;107(1):139-46. doi: 10.1016/j.rmed.2012.10.019. Epub 2012 Nov 28.

35.

[Prevention of recurrent lower urinary tract infections--a view from the past to the future].

Siniakova LA, Shteĭnberg ML.

Urologiia. 2012 Jul-Aug;(4):83-4, 86-7. Russian. No abstract available.

PMID:
23116031
36.

Clinical characteristics and outcomes of patients with clinically unsuspected pulmonary embolism versus patients with clinically suspected pulmonary embolism.

Shteinberg M, Segal-Trabelsy M, Adir Y, Laor A, Vardi M, Bitterman H.

Respiration. 2012;84(6):492-500. doi: 10.1159/000342324. Epub 2012 Sep 15.

37.

The impact of fluoroquinolone resistance of Gram-negative bacteria in respiratory secretions on the outcome of lung transplant (non-cystic fibrosis) recipients.

Shteinberg M, Raviv Y, Bishara J, Stein N, Rosengarten D, Bakal I, Kramer MR.

Clin Transplant. 2012 Nov-Dec;26(6):884-90. doi: 10.1111/j.1399-0012.2012.01665.x. Epub 2012 Jun 24.

PMID:
22724524
38.

Major respiratory adverse events after laparascopic gastric banding surgery for morbid obesity.

Avriel A, Warner E, Avinoach E, Avnon LS, Shteinberg M, Shteinberg D, Heimer D, Yona S, Maimon N.

Respir Med. 2012 Aug;106(8):1192-8. doi: 10.1016/j.rmed.2012.05.002. Epub 2012 Jun 5.

39.

[Actinomyces empyema treated with decortications].

Shteinberg M, Perek S, Ghanem N, Sarafov I, Peysakhovich Y, Adir Y.

Harefuah. 2012 Apr;151(4):205-7, 254. Hebrew.

PMID:
22616146
40.

[The overlap syndrome: obstructive sleep apnea and chronic obstructive pulmonary disease].

Shteinberg M, Weiler-Ravel D, Adir Y.

Harefuah. 2009 May;148(5):333-6, 348. Review. Hebrew.

PMID:
19630366
41.

Desensitization therapy in a patient with furosemide allergy.

Shteinberg M, Karkabi B, Cohen S.

Eur J Intern Med. 2007 Jan;18(1):69-70.

PMID:
17223047
42.

Clinical and biological characterization of macroprolactinemia with and without prolactin-IgG complexes.

De Schepper J, Schiettecatte J, Velkeniers B, Blumenfeld Z, Shteinberg M, Devroey P, Anckaert E, Smitz J, Verdood P, Hooghe R, Hooghe-Peters E.

Eur J Endocrinol. 2003 Sep;149(3):201-7.

PMID:
12943522
43.
44.

[Central alveolar hypoventilation in adults--Ondine's curse].

Shteinberg M, Edoute Y.

Harefuah. 2000 Feb 1;138(3):234-6. Review. Hebrew. No abstract available.

PMID:
10883100
45.

Phosphorylation of Cdc20/fizzy negatively regulates the mammalian cyclosome/APC in the mitotic checkpoint.

Yudkovsky Y, Shteinberg M, Listovsky T, Brandeis M, Hershko A.

Biochem Biophys Res Commun. 2000 May 10;271(2):299-304.

PMID:
10799291
46.

Phosphorylation of the cyclosome is required for its stimulation by Fizzy/cdc20.

Shteinberg M, Protopopov Y, Listovsky T, Brandeis M, Hershko A.

Biochem Biophys Res Commun. 1999 Jun 24;260(1):193-8.

PMID:
10381365
47.

Role of Suc1 in the activation of the cyclosome by protein kinase Cdk1/cyclin B.

Shteinberg M, Hershko A.

Biochem Biophys Res Commun. 1999 Apr 2;257(1):12-8.

PMID:
10092502
48.

Binding of activated cyclosome to p13(suc1). Use for affinity purification.

Sudakin V, Shteinberg M, Ganoth D, Hershko J, Hershko A.

J Biol Chem. 1997 Jul 18;272(29):18051-9.

49.

[Clinical features of collagenosis in children].

Shteĭnberg MA, Cherikover IaA.

Vestn Dermatol Venerol. 1968 Nov;42(11):79-83. Russian. No abstract available.

PMID:
5747699
50.

[Torulosis meningitis].

Shteĭnberg MG, Vasil'ev AV.

Zh Nevropatol Psikhiatr Im S S Korsakova. 1968;67(8):1131-3. Russian. No abstract available.

PMID:
5680517

Supplemental Content

Loading ...
Support Center